We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The of the Medicines and Healthcare products Regulatory Agency is set to leave the agency in 10 months. Ian Hudson’s decision means the agency faces the prospect of changing leaders while dealing with the fallout from Brexit.
The of the Medicines and Healthcare products Regulatory Agency is set to leave the agency in 10 months. Ian Hudson’s decision means the agency faces the prospect of changing leaders while dealing with the fallout from Brexit.